Retail sale of other new goods
NORSEPHARMA AS
Revenue 2025
NOK 52,000
Operating profit
NOK 36,000
Equity
NOK 77,000
Incorporated
2018
Share capital
NOK 40,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 52k | |
| Total operating costs | 16k | |
| Operating profit (EBIT) | 36k | |
| Profit for the year | 36k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 86k | |
| of which current assets | 86k | |
| Equity | 77k | |
| Total liabilities | 9k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.